Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-07-18FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Desoximetasone from Sun Pharmaceutical Industries, updating or expanding its labeling.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: A Single-Center, Prospective, Pilot Study to Compare the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy
A single-center, prospective pilot study evaluated whether dietary changes influence the effectiveness of light therapy in overweight or obe…
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Efficacy and Safety Study of Calcipotriol Betamethasone Plus Calcipotriol in Sequential Therapy to Psoriasis [NA]
A completed clinical trial evaluating the efficacy and safety of sequential therapy with calcipotriol and betamethasone followed by calcipot…
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Efficacy and Safety Study of Total Glucosides of Paeony Combined With Acitretin to Treat Psoriasis [NA]
This document reports a completed clinical trial evaluating the combination of Total Glucosides of Paeony with Acitretin for psoriasis, focu…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream [Phase 2]
Phase 2 trial evaluating the duration of use experience with Alclometasone Dipropionate Cream has completed with results posted in 2014.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-07-14FDA Approved: FLUOCINONIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's Original Application for fluocinonide, a topical corticosteroid, as a generic product. This marks regulatory cle…
-
FDA approval · 2014-07-14FDA Approved: FLUOCINONIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved an original application for fluocinonide from Sun Pharmaceutical Industries, a topical corticosteroid. The product is indicated…
-
FDA approval · 2014-07-03FDA Approved: CALCIPOTRIENE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for CALCIPOTRIENE submitted by Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: Methotrexate Polyglutamates as a Marker of Clinical Response and Toxicity in the Treatment of Psoriasis
A clinical trial investigates methotrexate polyglutamates as biomarkers for response and toxicity in psoriasis treatment.
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Golimumab Plus UVB-311nm in Psoriasis [NA]
A clinical trial evaluating golimumab plus UVB-311 nm phototherapy for psoriasis has been terminated. The study was sponsored by the Medical…
-
CLINICAL_TRIALS trial_result · 2014-06-19Clinical Trial Update: Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis [Phase 2]
Phase 2 double-blind, randomized, placebo-controlled trial of BIRT 2584 XX in patients with moderate-to-severe psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022) [Phase 1]
This Phase 1 study evaluated the safety, pharmacokinetics, and preliminary efficacy of MK-0873 for plaque psoriasis and has completed with r…
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test [Phase 1, Phase 2]
This trial update reports on the efficacy, tolerability, and safety of LAS41004 formulations in a psoriasis plaque test across Phase 1 and P…
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 study evaluating CP-690,550 (tofacitinib) with treatment withdrawal and retreatment in moderate to severe chronic plaque psoriasis; …
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study [Phase 2]
A Phase 2 trial of Desoximetasone Spray 0.25% for psoriasis completed, with results posted to evaluate safety related to HPA axis function.
-
FDA approval · 2014-05-12FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA has approved a supplemental application for Desoximetasone from Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 randomized trial comparing CP-690,550 and etanercept in moderate-to-severe chronic plaque psoriasis; completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis [Phase 2]
Phase 2 trial evaluating the safety and effectiveness of doxercalciferol capsules in participants with moderate to severe chronic plaque pso…
-
CLINICAL_TRIALS research · 2014-04-25Clinical Trial Update: Comparing Mindfulness Based Cognitive Therapy and Mindfulness Based Self-compassion Therapy in a Psoriasis Sample [NA]
This document provides an update on a clinical trial comparing mindfulness-based cognitive therapy and mindfulness-based self-compassion the…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis
This clinical trial update notes the completion of an observational safety study of etanercept (Enbrel) for psoriasis. Results were posted i…
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g [Phase 3]
This update reports the completion of a Phase 3 safety study of Raptiva (efalizumab) in adults with plaque psoriasis previously enrolled in …
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: A Long-term Safety Study of Infliximab (Remicade)
The document reports the completion of a long-term safety study of infliximab (Remicade) across rheumatoid arthritis, Crohn's disease, and p…
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis [Phase 3]
Phase 3 trial evaluating safety and efficacy of infliximab in Chinese patients with moderate-to-severe plaque-type psoriasis has completed. …
-
CLINICAL_TRIALS research · 2014-03-13Clinical Trial Update: Analysis Of The Influence Of Metabolic Syndrome On Treatment Efficacy With Anti-Tnf In Moderate-Severe Psoriasis In Real Clinical Practice.
A study analyzing whether metabolic syndrome influences the real-world efficacy of anti-TNF therapy in adults with moderate-to-severe psoria…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: LEO 90105 Ointment in Japanese Subjects With Psoriasis [Phase 3]
Phase 3 trial results for LEO 90105 Ointment in Japanese subjects with psoriasis have been completed and posted.